semaglutide injection vial Compounded for Women Eris brings breakthrough diabetes therapy

Women with obesity are more likely to experience anovulation (absence of ovulation), irregular menstrual cycles, and polycystic ovary syndrome (PCOS), a common endocrine disorder affecting fertility

In the four-year XENDOS trial, people taking it lost an average of 5.8 kg versus 3.0 kg on placebo, and had a lower risk of developing type 2 diabetes

Bariatric surgery and GLP-1 medications are two evidence-based options your care team may discuss with you if you have a higher body mass index or BMI, or if you have weight-related health conditions such as type 2 diabetes

Can semaglutide provide any health benefits along with supporting weight loss